George D Kalliolias
Overview
Explore the profile of George D Kalliolias including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
1703
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kalliolias G, Papavassiliou A
Pharmacol Res
. 2024 Dec;
210:107537.
PMID: 39645066
No abstract available.
2.
Wang B, Golubov J, Oswald E, Poon P, Wei Q, Lett C, et al.
EBioMedicine
. 2024 Sep;
108:105334.
PMID: 39270622
Background: Passive administration of SARS-CoV-2 neutralizing monoclonal antibodies (mAbs), such as CAS + IMD (Casirivimab + Imdevimab) antibody cocktail demonstrated beneficial effects on clinical outcomes in hospitalized patients with COVID-19...
3.
Kalliolias G, Papavassiliou A
Arthritis Res Ther
. 2024 Jul;
26(1):135.
PMID: 39026358
With great interest, we have read the recent article "Expression of HIF1α in intestinal epithelium restricts arthritis inflammation by inhibiting RIPK3-induced cell death machinery" published by Lyu et al. in...
4.
Kalliolias G, Papavassiliou A
Nat Rev Rheumatol
. 2024 Apr;
20(7):391-392.
PMID: 38609647
No abstract available.
5.
Targeting TLR Signaling Cascades in Systemic Lupus Erythematosus and Rheumatoid Arthritis: An Update
Kalliolias G, Basdra E, Papavassiliou A
Biomedicines
. 2024 Jan;
12(1).
PMID: 38255243
Evidence from animal models and human genetics implicates Toll-like Receptors (TLRs) in the pathogenesis of Systemic Lupus Erythematosus (SLE) and Rheumatoid Arthritis (RA). Endosomal TLRs sensing nucleic acids were proposed...
6.
How to improve translatability and clinical relevance of preclinical studies in rheumatoid arthritis
Kalliolias G, Basdra E, Papavassiliou A
Immunology
. 2023 Dec;
171(3):440-443.
PMID: 38148686
No abstract available.
7.
Kalliolias G, Basdra E, Papavassiliou A
Cancers (Basel)
. 2023 Nov;
15(22).
PMID: 38001700
Since the initial observation that patients with rheumatoid arthritis (RA) have an excess risk of developing hematologic malignancies [...].
8.
Wang C, Haxhinasto S, Garcet S, Kunjravia N, Cueto I, Gonzalez J, et al.
J Invest Dermatol
. 2022 Aug;
143(1):87-97.e14.
PMID: 35934055
Palmoplantar pustular psoriasis (PPPP) and non‒pustular palmoplantar psoriasis (NPPP) are localized, debilitating forms of psoriasis. The inflammatory circuits involved in PPPP and NPPP are not well-understood. To compare the cellular...
9.
Kosloski M, Kalliolias G, Xu C, Harel S, Lai C, Zheng W, et al.
Clin Transl Sci
. 2021 Sep;
15(2):384-395.
PMID: 34523807
Itepekimab is a monoclonal antibody that targets interleukin (IL-33) and has been shown to reduce airway inflammation and associated tissue damage in preclinical studies. We assessed the safety, tolerability, pharmacokinetics...
10.
Singh V, Kalliolias G, Ostaszewski M, Veyssiere M, Pilalis E, Gawron P, et al.
Database (Oxford)
. 2020 Apr;
2020.
PMID: 32311035
Rheumatoid arthritis (RA) is a progressive, inflammatory autoimmune disease of unknown aetiology. The complex mechanism of aetiopathogenesis, progress and chronicity of the disease involves genetic, epigenetic and environmental factors. To...